Many of our investments begin with creative ideas that leverage novel scientific approaches, or proprietary IP for fueling unique solutions. We invest at all phases of a company’s lifecycle beginning with incubating a novel idea. Our world-class team of business and science experts advance entrepreneurial passion by leveraging our platforms and expertise. Our global ecosystem, mentors and supports CEOs in complex business initiatives as well as day-to-day operations, enabling numerous successful outcomes.
Preclinical cancer drug discovery, small molecule, large molecule and cell therapy are key areas of focus. Our portfolio company, BioArdis is breaking new ground in these areas. BioAtla, our Drug Discovery services platform, is revolutionizing cancer therapies with leading-edge CAB technology, achieving greater efficacy and cost efficiencies. BioDuro, one of our earliest biopharma ventures, continues to prove itself as a global leader in pharmaceutical manufacturing. It is the third largest CRDMO.